Results
|
|
32501.
|
|
|
|
32502.
|
|
|
|
32503.
|
|
|
|
32504.
|
|
|
|
32505.
|
|
|
|
32506.
|
|
|
|
32507.
|
|
|
|
32508.
|
|
|
|
32509.
|
|
|
|
32510.
|
|
|
|
32511.
|
|
|
|
32512.
|
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). [electronic resource] by
- Schachter, Jacob
- Ribas, Antoni
- Long, Georgina V
- Arance, Ana
- Grob, Jean-Jacques
- Mortier, Laurent
- Daud, Adil
- Carlino, Matteo S
- McNeil, Catriona
- Lotem, Michal
- Larkin, James
- Lorigan, Paul
- Neyns, Bart
- Blank, Christian
- Petrella, Teresa M
- Hamid, Omid
- Zhou, Honghong
- Ebbinghaus, Scot
- Ibrahim, Nageatte
- Robert, Caroline
Producer: 20180927
In:
Lancet (London, England) vol. 390
Availability: No items available.
|
|
|
32513.
|
|
|
|
32514.
|
|
|
|
32515.
|
|
|
|
32516.
|
|
|
|
32517.
|
|
|
|
32518.
|
|
|
|
32519.
|
|
|
|
32520.
|
|